News Room
| NO | Title | Date | Viewers |
|---|---|---|---|
| 9 | Hanall Biopharma, Applied the Clinical Trial Phase 1 for New Medicine of Dry Eye Diseases | 2015-02-23 | 1867 |
| 8 | Hanall, Sponsoring Daily Supplies worth 17 million KRW for the neglected in pain of xerosis | 2015-01-07 | 1945 |
| 7 | Hanall Biopharma, Sponsoring Medicines worth 82 million KRW to Community Chest of Korea | 2015-01-07 | 1802 |
| 6 | Hanall Biopharma Received the “2014 Grand Prize of King Sejong Voluntary Service of Sharing” | 2014-12-09 | 1718 |
| 5 | Hanall is Entering into the 60 Billion KRW Market with Peptic Ulcer Drug “Wibis Tab” | 2014-12-01 | 2027 |
| 4 | Hanall Biopharma, Achieving Surplus for Three Consecutive Quarters | 2014-11-21 | 1793 |
| 3 | Hanall Completed the CGMP-class Production Plant for Cutting-edge Solid Formula | 2014-07-10 | 1850 |
| 2 | Hanall Biopharma, Achieving Net Income of 540M KRW to Turn into Surplus | 2014-05-23 | 1690 |
| 1 | Hanall Biopharma, Completed the Clinical Trial Phase 1 of “HL036,” New Medicine for Dry Eye Disease | 2014-04-27 | 1934 |